Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and Surgeons
Authors:
- Andrew W. DickADAndrew W. Dick
- Melony S. SorberoMSMelony S. Sorbero
- Gretchen M. AhrendtGAGretchen M. Ahrendt
- James A. HaymanJHJames A. Hayman
- Heather T. GoldHGHeather T. Gold
- Linda SchiffhauerLSLinda Schiffhauer
- Azadeh StarkASAzadeh Stark
- Jennifer J. GriggsJGJennifer J. Griggs
Open Access
- 3 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 103 (2) , 92-104
Abstract
The high incidence of ductal carcinoma in situ (DCIS) and variations in its treatment motivate inquiry into the comparative effectiveness of treatment options. Few such comparative effectiveness studies of DCIS, however, have been performed with detailed information on clinical and treatment attributes. We collected detailed clinical, nonclinical, pathological, treatment, and long-term outcomes data from multiple medical records of 994 women who were diagnosed with DCIS from 1985 through 2000 in Monroe County (New York) and the Henry Ford Health System (Detroit, MI). We used ipsilateral disease-free survival models to characterize the role of treatments (surgery and radiation therapy) and margin status (positive, close [ P diff < .001 for each of the differences). Similarly, each of the differences at 10 years was statistically significant ( P < .001). Our work demonstrates the contributions of treatments and margin status to long-term ipsilateral disease-free survival and the link between surgeons and these key measures of care. Although variation by surgeon could be generated by patients’ preferences, the extent of variation and its contribution to long-term health outcomes are troubling. Further work is required to determine why women with positive margins receive no additional treatment and why margin status and receipt of radiation therapy vary by surgeon.Keywords
This publication has 29 references indexed in Scilit:
- Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2009
- Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast CancerJAMA, 2009
- Decision Involvement and Receipt of Mastectomy Among Racially and Ethnically Diverse Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2009
- Effect of Margin Status on Local Recurrence After Breast Conservation and Radiation Therapy for Ductal Carcinoma In SituJournal of Clinical Oncology, 2009
- Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the BreastJournal of Clinical Oncology, 2008
- Predictors of Re-excision among Women Undergoing Breast-Conserving Surgery for CancerAnnals of Surgical Oncology, 2008
- Significance of Multifocality in Ductal Carcinoma In Situ: Outcomes of Women Treated With Breast-Conserving TherapyJournal of Clinical Oncology, 2007
- Lost Opportunities: Physicians' Reasons and Disparities in Breast Cancer TreatmentJournal of Clinical Oncology, 2007
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy GroupJournal of Clinical Oncology, 2006
- Correlates of Between-Surgeon Variation in Breast Cancer TreatmentsMedical Care, 2006